PharmaTher Holdings pecializes in the development and commercialization of ketamine-based medicines.
PharmaTher has raised $7.9M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in September 2021.
PharmaTher is headquartered in Toronto, Canada.
PharmaTher Holdings pecializes in the development and commercialization of ketamine-based medicines.
PharmaTher is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PharmaTher — Funding & Investors." VCBacked, September 24, 2021, https://www.vcbacked.co/company/pharmather. Accessed August 13, 2026.
VCBacked. (2021). PharmaTher — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/pharmather
{{cite web |title=PharmaTher — Funding & Investors |url=https://www.vcbacked.co/company/pharmather |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated